Successful treatment of an elderly patient with refractory ultraviolet-A-sensitive atopic eczema with mycophenolic acid

Acta Dermato-Venereologica

Volumn 88, Issue 4, 2008, Pages 404-405

  Bär, Michael ^a   Schmitt, Jochen ^a   Bauer, Andrea ^a   Wozel, Gottfried ^a   Meurer, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; ANTIHISTAMINIC AGENT; BETAMETHASONE; CORTICOSTEROID DERIVATIVE; HYDROCHLOROTHIAZIDE; MYCOPHENOLIC ACID; PREDNISOLONE; RAMIPRIL; VALSARTAN;

AGED; ANAMNESIS; ATOPIC DERMATITIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; HYPERTENSION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION;

AGED, 80 AND OVER; DERMATITIS, ATOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; ULTRAVIOLET RAYS;

EID: 47749086684     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0453     Document Type: Letter

References (11)

1. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352: 2314-2324.
2. Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics 2003; 21: 105-113.
3. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003; 148 Suppl 63: 3-10.
4. Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007; 87: 100-111.
5. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial. Lancet 2006; 367: 839-846.
6. Schmitt J, Schmitt NM, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. JEADV 2007; 21: 606-619.
7. Berth-Jones J, Takwale A, Tan E, Barclay G, Agarwal S, Ahmed I, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002; 147: 324-330.
8. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004; 50: 391-04.
9. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol 2001; 137: 870-873.
10. Heller M, Shin HT, Orlow SJ, Schaffer JW. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol 2007; 157: 127-132.
11. Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol 2000; 143: 385-391.